{"ticker": {"uuid": "6d53d4d0-b6ae-4796-8a4c-e7341d417631", "symbol": "2186", "name": "Luye Pharma Group Ltd.", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "A Look At Ascentage Pharma Group International\u2019s Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYjk2WWd1YXZWeXYyZFNjTVc0Y3htdnJsRVJGTWRzbzZYQVk0dUlMOWF2WHJEN0tlLTd4d25UWHBEVGhEQXV5c3NIVlIzWER5SHk0ZkJxWFBBVnd4c3VKWER3ajRfN3RvNjdZanMwRk14b1VjTHhTMWlrN1djWHZ1ZGRySGhGM3psU2ZRMXdWUURiV0poMUE3dV9LY1Z2ekRlTEJiY1d4MC1MZw?oc=5", "source_name": "Market source", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HKG:2186 - Luye Pharma Group Stock Price Forecast. Should You Buy 2186.HK?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTEFVX3lxTE5mNE5obGpzeVRkbDEtWlgybldqX1psc2dWY1VKM1NfUTdDTW53b0dKNlBROHQwZUF4cEljb0doT2xCQ3k0eEkza2xZOEg?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-16T10:10:47+00:00", "published_display": "16 Dec 2020 10:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "A Look At Ascentage Pharma Group International\u2019s Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYjk2WWd1YXZWeXYyZFNjTVc0Y3htdnJsRVJGTWRzbzZYQVk0dUlMOWF2WHJEN0tlLTd4d25UWHBEVGhEQXV5c3NIVlIzWER5SHk0ZkJxWFBBVnd4c3VKWER3ajRfN3RvNjdZanMwRk14b1VjTHhTMWlrN1djWHZ1ZGRySGhGM3psU2ZRMXdWUURiV0poMUE3dV9LY1Z2ekRlTEJiY1d4MC1MZw?oc=5", "source_name": "Market source", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HKG:2186 - Luye Pharma Group Stock Price Forecast. Should You Buy 2186.HK?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTEFVX3lxTE5mNE5obGpzeVRkbDEtWlgybldqX1psc2dWY1VKM1NfUTdDTW53b0dKNlBROHQwZUF4cEljb0doT2xCQ3k0eEkza2xZOEg?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-16T10:10:47+00:00", "published_display": "16 Dec 2020 10:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 54, "total_relevant": 2, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 1, "score": 58, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 58, "events": [{"event": "general", "label": "Market update", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1.92, "latest_week": "2026-07-10", "one_week_move": -5.4, "four_week_move": 1.6, "twelve_week_move": -33.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.695183, "market_dynamics_buy_signal": false, "relative_strength": -29.684133, "fair_value_gap": -33.6, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.6592, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.4% over one week, +1.6% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 1}, {"label": "StockInvest.us", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "58/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "58/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-5.4% over one week, +1.6% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "A Look At Ascentage Pharma Group International\u2019s Valuation After Recent Share Price Weakness"}], "updated_at": "2026-07-18T04:43:52.050058+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}